Concussion Treatment in Older Adults

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-99
SponsorUniversity of Pittsburgh

About this trial

The purpose of this study is to conduct the first randomized control trial for targeted treatments for concussion in adults 50 years or older. Participants will be enrolled at their first concussion clinical visit (V1) and their second study visit will occur after (up to 7 days) or concurrently with the participant's second concussion clinical visit, typically (but not limited to) between 21-31 days from V1.

Eligibility criteria

Qualifiers

50 years of age or older

Diagnosed concussion within the last 4 days - 12 months

Must be recruited at their initial concussion appointment

Ability to read/write to complete study assessments/testing

Disqualifiers

Diagnosed major psychiatric disorders other than depression/anxiety (e.g., schizophrenia)

Diagnosed with moderate to severe brain injury or past brain surgery/malformations

Trial design

Treatments tested in this trial

  • Behavioral Control
  • Targeted Intervention

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators